Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Open Access
- 30 January 2009
- journal article
- research article
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 8 (1) , 4
Abstract
Background: Tuberculosis is a growing international health concern. It is the biggest killer among the infectious diseases in the world today. Early detection of drug resistance allows starting of an appropriate treatment. Resistance to drugs is due to particular genomic mutations in specific genes of Mycobacterium tuberculosis(MTB). The aim of this study was to identify the presence of Isoniazid (INH) and Rifampicin(RIF) drug resistance in new and previously treated tuberculosis (TB) cases using DNA sequencing. Methods: This study was carried out on 153 tuberculous patients with positive Bactec 460 culture for acid fast bacilli. Results: Of the 153 patients, 105 (68.6%) were new cases and 48 (31.4%) were previously treated cases. Drug susceptibility testing on Bactec revealed 50 resistant cases for one or more of the first line antituberculous. Genotypic analysis was done only for rifampicin resistant specimens (23 cases) and INH resistant specimens (26 cases) to detect mutations responsible for drug resistance by PCR amplification of rpoB gene for rifampicin resistant cases and KatG gene for isoniazid resistant cases. Finally, DNA sequencing was done for detection of mutation within rpoB and KatG genes. Genotypic analysis of RIF resistant cases revealed that 20/23 cases (86.9%) of RIF resistance were having rpoB gene mutation versus 3 cases (13.1%) having no mutation with a high statistical significant difference between them (P < 0.001). Direct sequencing of Kat G gene revealed point mutation in 24/26 (92.3%) and the remaining 2/26 (7.7%) had wild type KatG i.e. no evidence of mutation with a high statistical significant difference between them (P < 0.001). Conclusion: We can conclude that rifampicin resistance could be used as a useful surrogate marker for estimation of multidrug resistance. In addition, Genotypic method was superior to that of the traditional phenotypic method which is time-consuming taking several weeks or longer.Keywords
This publication has 35 references indexed in Scilit:
- Newer diagnostics for tuberculosis and multi-drug resistant tuberculosisCurrent Opinion in Pulmonary Medicine, 2006
- Use of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex IsolatesJournal of Clinical Microbiology, 2005
- Molecular Analysis of Isoniazid-Resistant Mycobacterium tuberculosis Isolates from England and Wales Reveals the Phylogenetic Significance of the ahpC −46A PolymorphismAntimicrobial Agents and Chemotherapy, 2005
- Mycobacterium tuberculosisPathogenesis and Molecular Determinants of VirulenceClinical Microbiology Reviews, 2003
- Mutations in the rpoB Gene of Multidrug-Resistant Mycobacterium tuberculosis Isolates from ChinaJournal of Clinical Microbiology, 2003
- High Prevalence of KatG Ser315Thr Substitution among Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Northwestern Russia, 1996 to 2001Antimicrobial Agents and Chemotherapy, 2002
- rpoB Gene Mutations in Rifampin-Resistant Mycobacterium tuberculosis Identified by Polymerase Chain Reaction Single-Stranded Conformational PolymorphismEmerging Infectious Diseases, 2001
- Analysis for a Limited Number of Gene Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a High-Incidence CommunityJournal of Clinical Microbiology, 2001
- Frequency of rpoB Mutations Inside and Outside the Cluster I Region in Rifampin-Resistant Clinical Mycobacterium tuberculosis IsolatesJournal of Clinical Microbiology, 2001
- Mutations at Amino Acid Position 315 of thekatGGene Are Associated with High‐Level Resistance to Isoniazid, Other Drug Resistance, and Successful Transmission ofMycobacterium tuberculosisin The NetherlandsThe Journal of Infectious Diseases, 2000